Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Biological Psychiatry
|
August 17, 2002
Discovery and development of antidepressants: a perspective from a pharmaceutical discovery company
Edward M Scolnick
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 1, 2017
The Path to New Therapies for Schizophrenia and Bipolar Illness
Edward M Scolnick
Biological Psychiatry
|
April 18, 2006
Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations
Edward M Scolnick
Clinical & Translational Immunology
|
February 28, 2018
A vaccine to prevent cervical cancer: academic and industrial collaboration and a Lasker award
Edward M Scolnick
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 21, 2022
A Manhattan Project against COVID
Edward M Scolnick, Erica Ollmann Saphire
Harvard Review of Psychiatry
|
April 11, 2006
Schizophrenia: do the genetics and neurobiology of neuregulin provide a pathogenesis model?
Edward M Scolnick, Tracey Petryshen, Pamela Sklar
Nature Reviews. Drug Discovery
|
July 23, 2013
Validating therapeutic targets through human genetics
Robert M Plenge, Edward M Scolnick, David Altshuler
Analytical Biochemistry
|
February 28, 2003
Scintillation proximity assay of inositol phosphates in cell extracts: high-throughput measurement of G-protein-coupled receptor activation
Philip E Brandish, Lorraine A Hill, Wei Zheng, et al.
Journal of Biomolecular Screening
|
March 10, 2004
High-throughput cell-based screening using scintillation proximity assay for the discovery of inositol phosphatase inhibitors
Wei Zheng, Philip E Brandish, D Garrett Kolodin, et al.
Molecular Psychiatry
|
May 15, 2020
Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies
Sarah E Williams, Robert G Mealer, Edward M Scolnick, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Biological Psychiatry
|
August 17, 2002
Discovery and development of antidepressants: a perspective from a pharmaceutical discovery company
Edward M Scolnick
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 1, 2017
The Path to New Therapies for Schizophrenia and Bipolar Illness
Edward M Scolnick
Biological Psychiatry
|
April 18, 2006
Mechanisms of action of medicines for schizophrenia and bipolar illness: status and limitations
Edward M Scolnick
Clinical & Translational Immunology
|
February 28, 2018
A vaccine to prevent cervical cancer: academic and industrial collaboration and a Lasker award
Edward M Scolnick
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
January 21, 2022
A Manhattan Project against COVID
Edward M Scolnick, Erica Ollmann Saphire
Harvard Review of Psychiatry
|
April 11, 2006
Schizophrenia: do the genetics and neurobiology of neuregulin provide a pathogenesis model?
Edward M Scolnick, Tracey Petryshen, Pamela Sklar
Nature Reviews. Drug Discovery
|
July 23, 2013
Validating therapeutic targets through human genetics
Robert M Plenge, Edward M Scolnick, David Altshuler
Analytical Biochemistry
|
February 28, 2003
Scintillation proximity assay of inositol phosphates in cell extracts: high-throughput measurement of G-protein-coupled receptor activation
Philip E Brandish, Lorraine A Hill, Wei Zheng, et al.
Journal of Biomolecular Screening
|
March 10, 2004
High-throughput cell-based screening using scintillation proximity assay for the discovery of inositol phosphatase inhibitors
Wei Zheng, Philip E Brandish, D Garrett Kolodin, et al.
Molecular Psychiatry
|
May 15, 2020
Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies
Sarah E Williams, Robert G Mealer, Edward M Scolnick, et al.
Page
of 4